Plain-English translation of NCT06886282 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers have noticed that people with chronic kidney disease develop colon cancer more often than others, but nobody fully understands why. This study will compare tumor tissue from two groups of colon cancer patients—those with kidney disease and those without—to discover what might be causing this link. By studying the genes and structure of the tumors under the microscope, researchers hope to find clues that could improve how we prevent and treat colon cancer in people with kidney disease.
Doctors know that chronic kidney disease increases colon cancer risk, but the reasons are unclear. This study aims to close that gap by examining the tumor environment in detail, which could lead to better prevention and treatment strategies for this vulnerable population.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have blood work and imaging tests (an MRI scan) before your scheduled colon cancer surgery. During your surgery, doctors will collect a small sample of your tumor tissue, which will be frozen and analyzed using advanced genetic technology to study the tumor's environment. You will also answer questions about your medical history and kidney function. The study involves no additional visits or treatments beyond your regular cancer care.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy